Literature DB >> 2602535

Renal biopsy in patients with unexplained renal impairment and normal kidney size.

K Farrington1, D A Levison, R N Greenwood, W R Cattell, L R Baker.   

Abstract

We report renal biopsy findings in 109 patients with unexplained renal impairment (serum creatinine greater than 0.15 mmol/l) and normal-sized non-obstructed kidneys. The most common histological lesions were interstitial nephritis, rapidly progressive glomerulonephritis and a variety of other types of glomerulonephritis. The groups could not be distinguished by the presence or absence of hypertension, haematuria, proteinuria, or features of systemic disease. However interstitial nephritis was found more frequently in patients presenting with one or none of these features and rapidly progressive glomerulonephritis in patients presenting with three or more. All four patients with none of these features had interstitial lesions. Fifty-two per cent of patients with interstitial nephritis improved and 60 per cent of the patients with rapidly progressive glomerulonephritis who received immunosuppressive treatment improved or remained stable with treatment. The benefits of a biopsy diagnosis were almost wholly confined to these two groups. Complications were recorded in nine patients - prolonged macroscopic haematuria in six and symptomatic perirenal haematomata in three. Six required blood transfusion. One required nephrectomy to control haemorrhage and subsequently died. Percutaneous renal biopsy is not without risk in patients with renal impairment but the benefits of diagnosing interstitial nephritis and rapidly progressive glomerulonephritis outweigh the disadvantages.

Entities:  

Mesh:

Year:  1989        PMID: 2602535

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  13 in total

1.  Diffuse tubulointerstitial nephritis associated with ANCA-negative pauci-immune glomerulonephritis.

Authors:  Go Kanzaki; Nobuo Tsuboi; Takashi Yokoo; Yoichi Miyazaki; Yasunori Utsunomiya; Tatsuo Hosoya
Journal:  Clin Exp Nephrol       Date:  2012-01-24       Impact factor: 2.801

Review 2.  Drug-induced acute interstitial nephritis.

Authors:  Mark A Perazella; Glen S Markowitz
Journal:  Nat Rev Nephrol       Date:  2010-06-01       Impact factor: 28.314

3.  Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis.

Authors:  Shyam M Parkhie; Derek M Fine; Gregory M Lucas; Mohamed G Atta
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-25       Impact factor: 8.237

4.  Utility of urine eosinophils in the diagnosis of acute interstitial nephritis.

Authors:  Angela K Muriithi; Samih H Nasr; Nelson Leung
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 8.237

Review 5.  Acute kidney injury in the elderly.

Authors:  Khaled Abdel-Kader; Paul M Palevsky
Journal:  Clin Geriatr Med       Date:  2009-08       Impact factor: 3.076

6.  Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids.

Authors:  Maria Prendecki; Anisha Tanna; Alan D Salama; Frederick W K Tam; Tom Cairns; David Taube; H Terence Cook; Damien Ashby; Neil D Duncan; Charles D Pusey
Journal:  Clin Kidney J       Date:  2016-12-24

7.  Effect of steroids and relevant cytokine analysis in acute tubulointerstitial nephritis.

Authors:  Donghwan Yun; Myoung-Jin Jang; Jung Nam An; Jung Pyo Lee; Dong Ki Kim; Ho Jun Chin; Yon Su Kim; Dong-Sup Lee; Seung Seok Han
Journal:  BMC Nephrol       Date:  2019-03-12       Impact factor: 2.388

8.  Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial.

Authors:  Frank H Mose; Henrik Birn; Nikolai Hoffmann-Petersen; Jesper N Bech
Journal:  BMC Nephrol       Date:  2021-05-01       Impact factor: 2.585

Review 9.  Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician.

Authors:  Mark A Perazella
Journal:  Clin Nephrol       Date:  2014-06       Impact factor: 0.975

Review 10.  Proton Pump Inhibitors: More Indigestion than Relief?

Authors:  P Malavade; S Hiremath
Journal:  Indian J Nephrol       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.